• 본문 바로가기(Skip Contents)
ENGLISH
  • KOREAN
  • HOME

corestem

  • ABOUT US
    • Overview
    • History
    • Manufacturing facility
    • Our Company
  • PRODUCT
    • ALS (NeuroNata-R®)
    • Lou Gehrig's disease
  • PIPELINE
    • Pipeline
    • SLE
    • CA
  • R&D
    • Stem Cell Therapy
  • IR
    • Stock Information
    • Disclosures
    • Finances
    • Announcement of Settlement
    • IR Inquiry
  • PR
    • Press Report
    • Notice
    • Media
    • Online Inquiry

전체메뉴

전체메뉴

  • ABOUT US

    Overview History Manufacturing facility Our Company

  • PRODUCT

    ALS (NeuroNata-R®) Lou Gehrig's disease

  • PIPELINE

    Pipeline SLE CA

  • R&D

    Stem Cell Therapy

  • IR

    Stock Information Disclosures Finances Announcement of Settlement IR Inquiry

  • PR

    Press Report Notice Media Online Inquiry
  • HOME
ENGLISH
  • KOREAN
  • ABOUT US
    • Overview
    • History
    • Manufacturing facility
    • Our Company
  • PRODUCT
    • ALS (NeuroNata-R®)
    • Lou Gehrig's disease
  • PIPELINE
    • Pipeline
    • Target Disease
    • Lupus
  • R&D
    • Stem Cell Therapy
  • IR
    • Stock Information
    • Disclosures
    • Finances
    • Announcement of Settlement
    • IR Inquiry
  • PR
    • Press Report
    • Notice
    • Media
    • Online Inquiry

PR

Corestem is a biopharmaceutical company that researches and commercializes stem cell technology.

  • Press Report
  • Notice
  • Media
  • Online Inquiry
  • Press Report
  • Notice
  • Media
  • Online Inquiry

공지사항

11
2022.03
대표이사 서한 및 주요 경영사항 보고
READ MORE
24
2020.07
[공지사항] Neuronata-R FDA 임상 3상 승인
READ MORE
19
2020.03
공지 사항 - 미국 식품식약처 (FDA) IND 승인 여부의건
READ MORE
17
2019.07
전자증권 전환대상 주권 등의 권리자 보호 안내
READ MORE
19
2018.12
[공고]외부감사인 선임공고
READ MORE
  • 1
  • 2
  • ABOUT US
    Overview History Manufacturing facility Our Company
  • PRODUCT
    ALS (NeuroNata-R®) Lou Gehrig's disease
  • PIPELINE
    Pipeline Target Disease Lupus
  • R&D
    Stem Cell Therapy
  • IR
    Stock Information Disclosures Finances Announcement of Settlement IR relations
  • PR
    Press Report Notice Media Online Inquiry

Contact Information
  • 24, Pangyo-ro 255beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea
  • Gen (02) 497-3711
  • IR DID 070-4706-3546
  • FAX (02) 6349-8666
  • E-MAIL corestem@corestem.com
Copyright 2018 CORESTEM, Inc All right reserved.